Drug resistance mutations archived in resting memory CD4+ cells may persist despite suppression of HIV RNA to <50 copies/ml. We sequenced pol gene from proviral DNA among viremic and suppressed patients to identify drug resistance mutations..Among 120 subjects, 81% were on antiretroviral therapy and had been treated for a median time of 7 years. Thirty-two viremic patients showed concordant RNA and DNA genotypes (84%); the discordant profiles were mainly observed in patients with low-level viremia. Among suppressed patients, 21 had drug resistance mutations in proviral DNA (26%) with potential resistance to one, two or three ARV classes in 16, 4 and 1 samples respectively.The high level of genotype concordance between DNA and RNA in viremic...
International audienceObjectives In the context of a rilpivirine/emtricitabine/tenofovir disoproxil ...
In order to evaluate the usefulness of resistance testing after a viral rebound with plasma HIV RNA ...
Background: The impact of drug resistance mutational load and APOBEC editing in heavily treatment-ex...
BACKGROUND:Drug resistance mutations archived in resting memory CD4+ cells may persist despite suppr...
Background Drug resistance mutations archived in resting memory CD4+ cells may persist despite sup-p...
The extent to which HIV-1 proviral DNA mutations cause clinically relevant antiretroviral resistance...
BACKGROUND:Using HIV proviral DNA as a template may be suitable for initial detection of transmitted...
The extent to which HIV-1 proviral DNA mutations cause clinically relevant antiretroviral resistance...
International audienceObjectives: To investigate the extent to which drug resistance can be evaluate...
An improved understanding of the prevalence of low-abundance transmitted drug-resistance mutations (...
Drug-resistant HIV are more prevalent and persist longer than previously demonstrated by bulk sequen...
The aim of this study was to determine whether drug-resistant virus persists in peripheral blood mon...
Zidovudine (ZDV) is by far the most widely used drug to counteract human immunodeficiency virus type...
Research on human immunodeficiency virus type I (HIV-1) has led to the development and use of differ...
Background: The role of HIV-1 RNA in the emergence of resistance to antiretroviral therapies (ARTs) ...
International audienceObjectives In the context of a rilpivirine/emtricitabine/tenofovir disoproxil ...
In order to evaluate the usefulness of resistance testing after a viral rebound with plasma HIV RNA ...
Background: The impact of drug resistance mutational load and APOBEC editing in heavily treatment-ex...
BACKGROUND:Drug resistance mutations archived in resting memory CD4+ cells may persist despite suppr...
Background Drug resistance mutations archived in resting memory CD4+ cells may persist despite sup-p...
The extent to which HIV-1 proviral DNA mutations cause clinically relevant antiretroviral resistance...
BACKGROUND:Using HIV proviral DNA as a template may be suitable for initial detection of transmitted...
The extent to which HIV-1 proviral DNA mutations cause clinically relevant antiretroviral resistance...
International audienceObjectives: To investigate the extent to which drug resistance can be evaluate...
An improved understanding of the prevalence of low-abundance transmitted drug-resistance mutations (...
Drug-resistant HIV are more prevalent and persist longer than previously demonstrated by bulk sequen...
The aim of this study was to determine whether drug-resistant virus persists in peripheral blood mon...
Zidovudine (ZDV) is by far the most widely used drug to counteract human immunodeficiency virus type...
Research on human immunodeficiency virus type I (HIV-1) has led to the development and use of differ...
Background: The role of HIV-1 RNA in the emergence of resistance to antiretroviral therapies (ARTs) ...
International audienceObjectives In the context of a rilpivirine/emtricitabine/tenofovir disoproxil ...
In order to evaluate the usefulness of resistance testing after a viral rebound with plasma HIV RNA ...
Background: The impact of drug resistance mutational load and APOBEC editing in heavily treatment-ex...